Plant ID: NPO13015
Plant Latin Name: Pilosella officinarum
Taxonomy Genus: Pilosella
Taxonomy Family: Asteraceae
NCBI TaxonomyDB:
221204
Plant-of-the-World-Online:
n.a.
Astringent; Cholagogue; Diaphoretic; Diuretic; Expectorant; Tonic
Albania; Finland; Bulgaria
HPGD; |
Cytochrome P450 Enzymes: | CYP2C9; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Enzyme_unclassified | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:2001300; lipoxin metabolic process | 6.212E-04 | 9.705E-01 | HPGD |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 6.212E-04 | 9.705E-01 | CYP2C9 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 4.141E-04 | 9.705E-01 | CYP2C9 |
MF | GO:0005488; binding | GO:0048037; cofactor binding | 6.240E-04 | 9.705E-01 | CYP2C9, HPGD |
BP | GO:0008152; metabolic process | GO:0070988; demethylation | 6.100E-03 | 1.000E+00 | CYP2C9 |
BP | GO:0008283; cell proliferation | GO:0048661; positive regulation of smooth muscle cell proliferation | 7.854E-03 | 1.000E+00 | HPGD |
CC | GO:0016020; membrane | GO:0016323; basolateral plasma membrane | 1.917E-02 | 1.000E+00 | HPGD |
MF | GO:0003824; catalytic activity | GO:0016614; oxidoreductase activity, acting on CH-OH group of donors | 1.403E-02 | 1.000E+00 | HPGD |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 1.650E-02 | 1.000E+00 | CYP2C9 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 2.898E-03 | 1.228E-02 | CYP2C9 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 6.191E-03 | 1.228E-02 | CYP2C9 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 6.490E-03 | 1.228E-02 | CYP2C9 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 6.888E-03 | 1.228E-02 | CYP2C9 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 7.287E-03 | 1.228E-02 | CYP2C9 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 1.117E-02 | 1.436E-02 | CYP2C9 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 8.183E-03 | 1.228E-02 | CYP2C9 |
09160 Human Diseases | 09161 Cancers | hsa05202 | Transcriptional misregulation in cancer | 1.792E-02 | 2.016E-02 | HPGD |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.201E-01 | 1.201E-01 | CYP2C9 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9; |